Frank J Williams bought EVH once, on Dec 3, 2019
Director at Evolent Health, Inc.
SEC CIK 0001204938 · Filings on SEC.gov ↗
Frank J Williams's record
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
41 filings since Sep 2016, newest first
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Director
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
Executive Chair
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
Evolent Health, Inc.
CEO
About Frank J Williams
Frank J. Williams is a prominent healthcare executive and co-founder of Evolent Health, Inc. (NYSE: EVH), where he previously served as Chairman and CEO from 2011 to 2020, leading the company through its IPO, growth to over $1B in annualized revenue, and service to more than 15 million patients nationwide.( Prior to Evolent, he was Chairman and CEO of The Advisory Board Company (NASDAQ: ABCO), scaling it to $450M+ in annual revenues, over 2,500 employees, and $2B+ market capitalization post-IPO, and held roles as President of MedAmerica OnCall, President of Vivra Orthopedics, and Consultant at Bain & Co.( He earned a BA with High Honors in Political Economies of Industrial Societies from the University of California, Berkeley, and an MBA from Harvard Business School.(
Williams transitioned from Evolent's CEO role and retired from its Board of Directors in 2023 after serving as a director.( Currently, he is Chairman of the Board at Wellth, serves on boards including Syapse, Foodsmart, Nayya, Trusted Health, and Peer Health Exchange, and acts as a senior advisor to TPG Growth and The Rise Fund while contributing to health policy initiatives.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.